Works matching AU Zhang, Mengni

Results: 55
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22

    The heterogeneity of intraductal carcinoma of the prostate is associated with different efficacy of standard first‐line therapy for patients with metastatic castration‐resistant prostate cancer.

    Published in:
    Prostate, 2021, v. 81, n. 15, p. 1191, doi. 10.1002/pros.24215
    By:
    • Wang, Zhipeng;
    • Zhu, Sha;
    • Zhao, Jinge;
    • Nie, Ling;
    • Chen, Xueqin;
    • Zhang, Mengni;
    • Chen, Ni;
    • Sun, Guangxi;
    • Chen, Junru;
    • Ni, Yuchao;
    • Dai, Jindong;
    • Liu, Zhenhua;
    • Tao, Ronggui;
    • Zhang, Xingming;
    • Zhu, Xudong;
    • Zhang, Haoran;
    • Liang, Jiayu;
    • Wang, Zilin;
    • He, Ben;
    • Shen, Pengfei
    Publication type:
    Article
    23
    24

    AKR1C3 expression in primary lesion rebiopsy at the time of metastatic castration‐resistant prostate cancer is strongly associated with poor efficacy of abiraterone as a first‐line therapy.

    Published in:
    Prostate, 2019, v. 79, n. 13, p. 1553, doi. 10.1002/pros.23875
    By:
    • Zhao, Jinge;
    • Zhang, Mengni;
    • Liu, Jiandong;
    • Liu, Zhenhua;
    • Shen, Pengfei;
    • Nie, Ling;
    • Guo, Wenhao;
    • Cai, Diming;
    • Liu, Jiyan;
    • Armstrong, Cameron M.;
    • Sun, Guangxi;
    • Chen, Junru;
    • Zhu, Sha;
    • Dai, Jindong;
    • Zhang, Haoran;
    • Zhao, Peng;
    • Zhang, Xingming;
    • Yin, Xiaoxue;
    • Zhu, Xudong;
    • Ni, Yuchao
    Publication type:
    Article
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50